1-7 of 7
Kristina Ellwanger
Close
Sort by
Journal Articles

Cryopreserved CAR-like NK Cells Pre-Complexed with the CD30/CD16A Bispecific Innate Cell Engager (ICE®) AFM13 for the Treatment of CD30 + Malignancies

Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Thomas Müller, Ute Schniegler-Mattox, Jens Pahl, Michael Tesar, Joachim Koch
Journal: Blood
Blood (2021) 138 (Supplement 1): 3992.
https://doi.org/10.1182/blood-2021-150552
Published: 2021
Journal Articles

Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma

Thorsten Ross, PhD, Uwe Reusch, PhD, Susanne Wingert, PhD, Torsten Haneke, PhD, Katja Klausz, PhD, Anna-Kathrin Otte, PhD, Natalie Schub, MD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Thomas Valerius, MD, Martin Gramatzki, MD, Matthias Peipp, PhD, Michael Tesar, PhD, Erich Rajkovic, PhD MBA, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1927.
https://doi.org/10.1182/blood-2018-99-118970
Published: 2018
Journal Articles

AFM26 - Targeting B Cell Maturation Antigen (BCMA) for NK Cell-Mediated Immunotherapy of Multiple Myeloma

Thorsten Gantke, PhD, Uwe Reusch, PhD, Christian Kellner, PhD, Katja Klausz, PhD, Torsten Haneke, PhD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Anne Kerber, MD, Matthias Peipp, PhD, Martin Treder, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3082.
https://doi.org/10.1182/blood.V130.Suppl_1.3082.3082
Published: 2017
Journal Articles

Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma

Thorsten Gantke, PhD, Michael Weichel, PhD, Uwe Reusch, PhD, Kristina Ellwanger, PhD, Ivica Fucek, Remko Griep, PhD, Vera Molkenthin, PhD, Oscar Kashala, MD PhD DSc, Martin Treder, PhD
Journal: Blood
Blood (2016) 128 (22): 4513.
https://doi.org/10.1182/blood.V128.22.4513.4513
Published: 2016
Journal Articles

In Vitro and In Vivo Characterization of CD19/CD3 Tandab AFM11 and CD19/CD16A Tandab AFM12 Targeting NHL

Xing Zhao, Narendiran Rajasekaran, PhD, Uwe Reusch, PhD, Michael Weichel, Kristina Ellwanger, Jens-Peter Marschner, MD, Martin Treder, Holbrook Kohrt, MD
Journal: Blood
Blood (2015) 126 (23): 2763.
https://doi.org/10.1182/blood.V126.23.2763.2763
Published: 2015
Journal Articles

A CD19/CD3 Bispecific Tandab, AFM11, Recruits T Cells To Potently and Safely Kill CD19 + Tumor Cells

Eugene Zhukovsky, PhD, Uwe Reusch, Carmen Burkhardt, Stefan Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, Kristina Ellwanger, Melvyn Little, PhD
Journal: Blood
Blood (2013) 122 (21): 4405.
https://doi.org/10.1182/blood.V122.21.4405.4405
Published: 2013
Journal Articles

A T Cell-Engaging CD3 Recruit-Tandab Potently Kills CD19 + Tumor B Cells

Eugene Zhukovsky, PhD, Uwe Reusch, Carmen Burkhardt, Stefan Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, Kristina Ellwanger
Journal: Blood
Blood (2012) 120 (21): 3721.
https://doi.org/10.1182/blood.V120.21.3721.3721
Published: 2012